Enjoying this bite?
Sign in (free) to track this channel, unlock new bites the moment they drop, and search every summary we've ever made.
Source: YouTube. Summary is AI-generated from the video's captions and may contain errors. It does not represent the views of TubeBite, the creator, or YouTube. Watch the original before relying on anything important.
SUMMARY
Parkev Tatevosian, CFA, analyzes Chewy's recent stock decline following the company's downward revision of its 2026 sales outlook. The discussion covers the impact of economic pressures, management effectiveness, and valuation metrics to assess whether Chewy presents a buying opportunity.
MAIN POINTS
- Chewy stock is down 43% year-to-date in 2026 after lowering its fiscal 2026 sales outlook to $13.4–$13.5 billion due to a challenging market environment.
- Despite economic pressures, Chewy's first quarter net sales rose 7.7% year-over-year and gross profit margins improved, with management credited for effective navigation.
- Investment banks have downgraded Chewy's price targets, citing weak international expansion prospects and referencing other US retailers' struggles abroad.
- Chewy's financial trajectory shows significant improvement in cash flow from operations and operating profit margins since 2017, though the business remains capital-intensive.
- Chewy's valuation is considered attractive, with a forward P/E of 12.1 and shares trading near 52-week lows, well below calculated fair value.
- Chewy is viewed as a strong long-term buy below $25 per share, but investors should be prepared for ongoing consumer headwinds through 2026.
DETAILED ANALYSIS
Chewy has experienced a significant 43% decline in its stock price year-to-date in 2026, primarily triggered by the company's decision to lower its fiscal 2026 sales outlook to a range of $13.4 to $13.5 billion. This adjustment reflects broader economic challenges, including persistent inflation, higher tariffs, and elevated oil prices, all of which have reduced US consumers' disposable income. As a result, Chewy's sales in discretionary categories such as pet toys and accessories have softened, though demand for essential items like pet food and medicine remains stable.
Despite these headwinds, Chewy reported a 7.7% year-over-year increase in first quarter net sales, surpassing expectations, and achieved improvements in gross profit margins. The management team is credited with effectively steering the company through volatile conditions since the pandemic, as evidenced by the company's improved financial metrics. Notably, Chewy's cash flow from operations to sales ratio has risen from -3.8% in 2017 to 5.5% in 2025, and its operating profit margin has increased from -16% to 2% over the same period.
While these absolute figures are modest, the positive trajectory signals operational progress.
However, several investment banks have issued downgrades and lowered price targets for Chewy, expressing skepticism about the company's international expansion prospects. Historical examples such as Best Buy, eBay, Walmart, and Target are cited, highlighting the difficulties US retailers face when attempting to grow overseas. Chewy's business model, which is capital-intensive due to its ownership of fulfillment and logistics operations, further distinguishes it from asset-light competitors and limits its potential for high profit margins, but also creates barriers to entry for competitors.
From a valuation perspective, Chewy's stock appears undervalued. The forward price-to-earnings ratio stands at 12.1, and the forward price-to-operating-cash-flow ratio is 9.3. Based on discounted cash flow analysis, the fair value is estimated at $34 per share, while the current market price hovers around $19, near its 52-week low.
For long-term investors, Chewy is considered an attractive opportunity below $25 per share, though caution is advised due to ongoing economic pressures that may persist throughout 2026.
LINKS
- YouTube channel membership for exclusive perks and early access.
- Special offer for The Motley Fool Stock Advisor.
- Parkev Tatevosian's book on evaluating publicly traded companies.
- Fiscal.ai research platform with a viewer discount.
- Webull investing platform sign-up with bonus shares.
- Subscription link for Parkev Tatevosian's Substack newsletter.